The fourth national serosurvey carried out by the Indian Council of Medical Research (ICMR) indicates that more than two-thirds of India’s population have developed antibodies against COVID-19. Conducted between June and July of 2021, the survey’s findings found 67.6 percent of the country’s 1.3 billion people presented with antibodies. This marks a substantial increase from …
There is no evidence to indicate a rise in tuberculosis (TB) cases due to the COVID-19 pandemic according to the Union Ministry of Health and Family Welfare. However, they do suggest that COVID-19 patients may be more susceptible to contracting TB and, as such, surveillance efforts ought to be scaled up. “Due to the impact …
COVID-19 and TB? Coronavirus patients more susceptible? Read More »
In an interview, INSACOG co-chair Dr N. K. Arora has said that COVID-19 vaccines are effective against the Delta variant. The Delta variant is a more transmissible strain of the novel coronavirus which emerged in India in October of last year. INSACOG refers to the Indian SARS-CoV-2 Genomics Consortium (INSACOG). It comprises 28 laboratories under …
COVID-19 vaccines effective against Delta variant: INSACOG co-chair Read More »
The Centre has raised the issue of COVID-19 rule-breaking with state and union territory governments. Prime Minister Narendra Modi recently expressed concerns over COVID-19 rule-breaking. “I will say very strongly that it is a matter of grave concern to see people without masks in the market and not following the protocol in hill stations,” he …
At the time of writing, COVID-19 officially has claimed more than 400,000 lives in India. Some believe the true death toll of COVID-19 to be considerably higher. In an interview with The Wire, data journalist Rukmini S. posits the actual number of fatalities to be 2.5 million including 1.5 million fatalities during the second wave. …
Drugmaker Moderna is said to have secured an offer of legal indemnity regarding its COVID-19 vaccine from the Government, albeit with certain provisions. Individuals familiar with the matter said an offer has been sent to the drugmaker, which is based in the United States, reports The Economic Times. The company’s board of directors are expected …
India needs to “be watchful” against the Lambda and Kappa variants of COVID-19, according to Dr Vinod K. Paul of government think tank Niti Aayog. The COVID-19 pandemic has witnessed the emergence of several variants, including the Delta variant which has been found in multiple countries which first emerged in India. The Lambda and Kappa …
So-called ‘long COVID’, where survivors of COVID-19 continue to experience debilitating symptoms even requiring hospitalisation, remains a concern for India’s healthcare system. As The Economic Times reports, “doctors are dealing with [a] rising number of long Covid patients with symptoms like persistent body ache, low grade fever, lung fibrosis, pulmonary embolism and brain fogging in …
India has commenced paediatric trials for Covaxin, its indigenously-manufactured vaccine against COVID-19. Covaxin, manufactured by Hyderabad-based firm Bharat Biotech, is one of four vaccines authorised for use in India alongside Covishield (produced by the Serum Institute of India on license from AstraZeneca), the Russian-manufactured Sputnik-V, and the Moderna vaccine. Bharat Biotech announced last month that …
The Moderna vaccine is to become available in India by July 15th, reports indicate. Cipla, a pharmaceutical firm based in Mumbai, received the nod to import doses of the Moderna vaccine from the Drug Controller General of India (DCGI) last month. It became the fourth COVID-19 vaccine to receive emergency use authorisation from the Centre …
Health Issues India is a web portal that tracks key health stories and issues in India. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues India | All rights reserved.
